Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 211

The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.

Targeting of acute myeloid leukaemia by cytokine‐induced killer cells redirected with a novel CD 123‐specific chimeric antigen receptor

Tettamanti, Sarah, Marin, Virna, Pizzitola, Irene, Magnani, Chiara F., Giordano Attianese, Greta M. P., Cribioli, Elisabetta, Maltese, Francesca, Galimberti, Stefania, Lopez, Angel F., Biondi, Andrea, Bonnet, Dominique, Biagi, Ettore · 2013 · British Journal of Haematology

Abstract

Summary: Current therapeutic regimens for acute myeloid leukaemia (AML) are still associated with high rates of relapse. Immunotherapy with T‐cells genetically modified to express chimeric antigen receptors (CAR s) represents an innovative approach. Here we investigated the targeting of the interleukin three receptor alpha (IL 3 RA; CD 123) molecule, which is overexpressed on AML bulk population, CD 34+ leukaemia progenitors, and leukaemia stem cells (LSC) compared to normal haematopoietic stem/progenitor cells (HSPC s), and whose overexpression is associated with poor prognosis. Cytokine‐induced killer (CIK) cells were transduced with SFG‐retroviral‐vector encoding an anti‐CD 123 CAR. Transduced cells were able to strongly kill CD 123+ cell lines, as well as primary AML blasts. Interestingly, secondary colony experiments demonstrated that anti‐CD 123.CAR preserved in vitro HSPCs, in contrast to a previously generated anti‐CD 33.CAR, while keeping an identical cytotoxicity profile towards AML. Furthermore, limited killing of normal monocytes and CD 123‐low‐expressing endothelial cells was noted, thus indicating a low toxicity profile of the anti‐CD 123.CAR. Taken together, our results indicate that CD 123‐specific CAR s strongly enhance anti‐AML CIK functions, while sparing HSPC s and normal low‐expressing antigen cells, paving the way to develop novel immunotherapy approaches for AML treatment.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/bjh.12282

Cites

4 of 4 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Cited by

See all 211

Metadata

Authors
Tettamanti, S., Marin, V., Pizzitola, I., Magnani, C. F., Giordano Attianese, G. M. P., Cribioli, E., Maltese, F., Galimberti, S., Lopez, A. F., Biondi, A., Bonnet, D., & Biagi, E.
Venue
British Journal of Haematology
Publisher
Wiley
Published
2013-02-25
Volume
161
Issue
3
Pages
389-401
ISSN
  • 0007-1048 (ISSN-L)
  • 1365-2141
OpenAlex
W1967995010
Cited by
211
References
4
FWCI
13.28
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.